Cargando…
Hypercalcemia affected in metastatic breast cancer patients without bone metastasis: report of three cases
BACKGROUND: Since humoral hypercalcemia of malignancy (HHM) in breast cancer patients without bone metastasis is rare, the clinical features of this condition are not fully understood. CASE PRESENTATION: During the recent 12 years, 3602 patients were diagnosed with breast cancer in our institution,...
Autores principales: | Hashizume, Sakina, Shimoda, Masafumi, Yoshinami, Tetsuhiro, Abe, Kaori, Masunaga, Nanae, Sota, Yoshiaki, Miyake, Tomohiro, Tanei, Tomonori, Shimazu, Kenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701264/ https://www.ncbi.nlm.nih.gov/pubmed/36435947 http://dx.doi.org/10.1186/s40792-022-01565-9 |
Ejemplares similares
-
Detection of Ultra-Rare ESR1 Mutations in Primary Breast Cancer Using LNA-Clamp ddPCR
por: Hashimoto, Yoko, et al.
Publicado: (2023) -
Evaluation of RASSF1A methylation in the lysate of sentinel lymph nodes for detecting breast cancer metastasis: A diagnostic accuracy study
por: Park, Sung Ae, et al.
Publicado: (2023) -
A case of sternal osteomyelitis during treatment with everolimus for recurrent breast cancer
por: Abe, Kaori, et al.
Publicado: (2022) -
Molecular Barcode Sequencing of the Whole Ligand Binding Domain of the ESR1 Gene in Cell-Free DNA from Patients with Metastatic Breast Cancer()
por: Masunaga, Nanae, et al.
Publicado: (2020) -
Detection of ctDNA with Personalized Molecular Barcode NGS and Its Clinical Significance in Patients with Early Breast Cancer
por: Yoshinami, Tetsuhiro, et al.
Publicado: (2020)